This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jomini, V. Articles by Mooser, V. Search for Related Content PubMed PubMed Citation Articles by Jomini, V. Articles by Mooser, V.

contribution of major cardiovascular risk factors to familial premature coronary artery disease

The GENECARD project

Vincent Jomini, MD^*, S.éverine Oppliger-Pasquali, MD^*, Vincent Wietlisbach, BA, Nicolas Rodondi, MD, Valérie Jotterand, MD^*, Fred Paccaud, MD, Roger Darioli, MD, Pascal Nicod, MD^* and Vincent Mooser, MD^*,*

^* Department of Medicine, CHUV University Hospital, Lausanne, Switzerland
Institute for Social and Preventive Medicine, CHUV University Hospital, Lausanne, Switzerland,
University Medical Policlinic, Lausanne, Switzerland

View larger version (39K): [in a new window]   Figure 1 Strategy used to recruit premature coronary artery disease (P-CAD)–affected sibling pairs and to identify patients with sporadic P-CAD. A total of 110 patients with familial P-CAD were originally identified, but 7 refused to enter the study, so that 103 probands with familial P-CAD and 110 affected siblings were eventually recruited.

View larger version (26K): [in a new window]   Figure 2 The prevalence of hypertension (HT), hypercholesterolemia (HC), obesity and cigarette smoking at the time of the event in 163 patients with familial premature coronary artery disease (P-CAD) (solid bars), 326 age- and gender-matched patients with sporadic (nonfamilial) P-CAD (hatched bars) and 489 age- and gender-matched individuals randomly sampled from the local general population (open bars). Hypertension was defined as blood pressure 160/95 mm Hg and/or prescription of antihypertensive agents; hypercholesterolemia corresponded to plasma total cholesterol levels 6.5 mmol/l and/or prescription of lipid-lowering agents; obesity was defined as a body mass index 30 kg/m2; and smoking corresponded to active cigarette smoking at the time of diagnosis or within the preceding five years. *p < 0.05; **p < 0.01; ***p < 0.001.

View larger version (18K): [in a new window]   Figure 3 The prevalence of risk factors in the general population (open diamonds), in patients with sporadic premature coronary artery disease (P-CAD) (solid triangles) and in patients with familial P-CAD (solid circles), according to age tertiles. Groups and risk factors were defined as described in the legend to Figure 2. *p < 0.05 familial versus sporadic P-CAD; ***p < 0.001.

View larger version (14K): [in a new window]   Figure 4 Aggregation of cardiovascular risk factors at the time of the event in six sibships with at least three siblings affected with premature coronary artery disease (P-CAD). Males are represented by squares and females by circles. The numbers beneath the symbols refer to the age when the diagnosis of P-CAD was made, whereas the age for the parents refers to the age at death (numbers in parentheses) or at the time that their P-CAD–affected siblings were recruited (age at death of the father for family no. 39 was unknown). Solid upper left corner = hypertension; solid lower left corner = smoking; solid upper right corner = hypercholesterolemia; and solid lower right corner = obesity and/or diabetes, as defined in the legend to Figure 2. Arrows indicate probands. Plasma cholesterol levels were missing for siblings 1 and 3 from family no. 53, sibling 1 from family no. 80 and sibling 1 from family no. 96, and the diagnosis of hypercholesterolemia was based on values obtained when these individuals were recruited. The father in family no. 80 died of P-CAD at age 49 years.